| Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall HG Rus, R Vlaicu, F Niculescu Atherosclerosis 127 (2), 263-271, 1996 | 489 | 1996 |
| The role of the complement system in innate immunity H Rus, C Cudrici, F Niculescu Immunologic research 33, 103-112, 2005 | 424 | 2005 |
| Membrane attack by complement: the assembly and biology of terminal complement complexes CA Tegla, C Cudrici, S Patel, R Trippe, V Rus, F Niculescu, H Rus Immunologic research 51, 45-60, 2011 | 328 | 2011 |
| Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. H Rus, F Niculescu, R Vlaicu Atherosclerosis 89 (2), 247-254, 1991 | 266 | 1991 |
| Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate C Ford, AD Goodman, K Johnson, N Kachuck, JW Lindsey, R Lisak, ... Multiple Sclerosis Journal 16 (3), 342-350, 2010 | 260 | 2010 |
| The voltage-gated potassium channel Kv1. 3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain H Rus, CA Pardo, L Hu, E Darrah, C Cudrici, T Niculescu, F Niculescu, ... Proceedings of the National Academy of Sciences 102 (31), 11094-11099, 2005 | 228 | 2005 |
| Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque R Vlaicu, F Niculescu, HG Rus, A Cristea Atherosclerosis 57 (2-3), 163-177, 1985 | 227 | 1985 |
| Persistent complement activation on tumor cells in breast cancer. F Niculescu, HG Rus, M Retegan, R Vlaicu The American journal of pathology 140 (5), 1039, 1992 | 203 | 1992 |
| Immunoglobulins and complement components in human aortic atherosclerotic intima R Vlaicu, HG Rus, F Niculescu, A Cristea Atherosclerosis 55 (1), 35-50, 1985 | 196 | 1985 |
| Sublytic complement attack induces cell cycle in oligodendrocytes. HG Rus, F Niculescu, ML Shin Journal of immunology (Baltimore, Md.: 1950) 156 (12), 4892-4900, 1996 | 157 | 1996 |
| Role of the C5b‐9 complement complex in cell cycle and apoptosis HG Rus, FI Niculescu, ML Shin Immunological reviews 180 (1), 49-55, 2001 | 149 | 2001 |
| Complement activation and atherosclerosis F Niculescu, H Rus Molecular immunology 36 (13-14), 949-955, 1999 | 146 | 1999 |
| Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase F Niculescu, T Badea, H Rus Atherosclerosis 142 (1), 47-56, 1999 | 142 | 1999 |
| Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation L Soane, H Rus, F Niculescu, ML Shin The Journal of Immunology 163 (11), 6132-6138, 1999 | 140 | 1999 |
| The role of complement activation in atherosclerosis F Niculescu, H Rus Immunologic research 30, 73-80, 2004 | 138 | 2004 |
| Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis F Niculescu, HG Rus, R Vlaicu Atherosclerosis 65 (1-2), 1-11, 1987 | 138 | 1987 |
| RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase T Badea, F Niculescu, L Soane, M Fosbrink, H Sorana, V Rus, ML Shin, ... Journal of Biological Chemistry 277 (1), 502-508, 2002 | 135 | 2002 |
| Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. F Niculescu, H Rus, T Van Biesen, ML Shin Journal of immunology (Baltimore, Md.: 1950) 158 (9), 4405-4412, 1997 | 126 | 1997 |
| Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation M Qiao, P Shapiro, M Fosbrink, H Rus, R Kumar, A Passaniti Journal of biological chemistry 281 (11), 7118-7128, 2006 | 125 | 2006 |
| C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway L Soane, HJ Cho, F Niculescu, H Rus, ML Shin The Journal of Immunology 167 (4), 2305-2311, 2001 | 124 | 2001 |
